These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Up to nine-years' experience with the Allcarbon prosthetic heart valve. Ho TH, Van Nguyen P, Phan PK, Pham VN. J Heart Valve Dis; 2005 Jul; 14(4):512-7. PubMed ID: 16116878 [Abstract] [Full Text] [Related]
25. Long-term outcomes of valve replacement with modern prostheses in young adults. Ruel M, Kulik A, Lam BK, Rubens FD, Hendry PJ, Masters RG, Bédard P, Mesana TG. Eur J Cardiothorac Surg; 2005 Mar; 27(3):425-33; discussion 433. PubMed ID: 15740951 [Abstract] [Full Text] [Related]
26. Comparative clinical outcomes with St. Jude Medical, Medtronic Hall and CarboMedics mechanical heart valves. Masters RG, Helou J, Pipe AL, Keon WJ. J Heart Valve Dis; 2001 May; 10(3):403-9. PubMed ID: 11380109 [Abstract] [Full Text] [Related]
27. Evaluation of valve-related complications in patients with Sorin Bicarbon prosthesis: a seven-year experience. Bortolotti U, Milano A, D'Alfonso A, Piccin C, Mecozzi G, Magagna P, Fabbri A, Mazzucco A. J Heart Valve Dis; 2001 Nov; 10(6):795-801. PubMed ID: 11767189 [Abstract] [Full Text] [Related]
28. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome. Kuwaki K, Tsukamoto M, Komatsu K, Morishita K, Sakata J, Abe T. J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788 [Abstract] [Full Text] [Related]
29. Long-term results with the Xenomedica porcine bioprosthesis in the mitral position. Santini F, Auriemma S, Casali G, Rossi A, Lusini M, Mazzucco A. J Heart Valve Dis; 2001 Nov; 10(6):789-94. PubMed ID: 11767188 [Abstract] [Full Text] [Related]
30. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. Yamak B, Iscan Z, Mavitas B, Ulus AT, Katircioglu SF, Tasdemir O, Bayazit K. J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246 [Abstract] [Full Text] [Related]
32. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes? Alsoufi B, Manlhiot C, McCrindle BW, Canver CC, Sallehuddin A, Al-Oufi S, Joufan M, Al-Halees Z. Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085 [Abstract] [Full Text] [Related]
34. Mechanical versus biological valve prosthesis in the mitral position: a 10-year follow up of St. Jude Medical and Biocor valves. Demirag M, Kirali K, Omeroglu SN, Mansuroglu D, Akinci E, Ipek G, Berki T, Gürbüz A, Isik O, Yakut C. J Heart Valve Dis; 2001 Jan; 10(1):78-83. PubMed ID: 11206772 [Abstract] [Full Text] [Related]
35. Six years' experience with the Omnicarbon valve prosthesis. Otaki M, Kitamura N. Cardiovasc Surg; 1993 Oct; 1(5):594-8. PubMed ID: 8076103 [Abstract] [Full Text] [Related]
36. Porcine versus pericardial bioprostheses: eleven-year follow up of a prospective randomized trial. Chaudhry MA, Raco L, Muriithi EW, Bernacca GM, Tolland MM, Wheatley DJ. J Heart Valve Dis; 2000 May; 9(3):429-37; discussion 437-8. PubMed ID: 10888102 [Abstract] [Full Text] [Related]
37. Use of the Carpentier-Edwards porcine bioprosthesis: assessment of a patient selection policy. Louagie Y, Noirhomme P, Aranguis E, Eucher P, Vanruyssevelt P, Buche M, Dion R, Jaumin P, Schoevaerdts JC, Chalant CH. J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1013-24. PubMed ID: 1405658 [Abstract] [Full Text] [Related]